Bioconjugate structures vs. composite nanoparticulate carriers: the battle for the future of smart, effective and safe cancer management  

作　　者：Mohamed Ismail Nounou 

机构地区：[1]Department of Pharmaceutical Sciences,School of Pharmacy,University of Saint Joseph,Hartford,CT 06103,USA

出　　处：《Journal of Cancer Metastasis and Treatment》2018年第1期348-350,共3页癌症转移与治疗（英文版）

摘　　要：For the past couple of decades,academic research has been mainly focusing on novel carrier systems and nanoparticulate colloidal technologies for drug delivery,such as nanoparticles,nanospheres,vesicular systems,liposomes,nanocapsules,etc.Such efforts aided in the creation of newly marketed products such as Doxil®in the market[1,2].

关 键 词：COMPOSITE CONJUGATE NANOPARTICLES 

分 类 号：TB3[一般工业技术—材料科学与工程]